A Gloucester County pharmacist has agreed to sell her business after New Jersey regulators say she kept filling prescriptions from an unsafe drug supply even after her license was suspended, in a case connected to a patient's death. Nittal K. Lodha must divest her financial interest in Woodbury Family Pharmacy to a board-approved buyer within 90 days under a consent order announced by the state.
The forced sale caps a rapid escalation that began with a state investigation opened in 2024 and culminated this summer in one of the more severe pharmacy enforcement actions in recent South Jersey history. According to state filings reported by The Jersey Vindicator, an unnamed male patient died after being forced to ration his medication and take expired drugs because Lodha repeatedly refused to transfer his prescriptions to another pharmacy — a circumstance his physician said contributed to his death. That allegation, highlighted by the state pharmacy board in its initial suspension filing, gave the case its gravity from the outset.
A Pattern of Refused Transfers
State reporting from July 2026 found that when patients tried to move their care elsewhere, Lodha refused to transfer their prescription files, per the same Jersey Vindicator account. New Jersey Attorney General Jennifer Davenport's office says Lodha repeatedly disregarded patients' requests to stop filling prescriptions and to transfer them elsewhere, and some patients were forced to ration their medications or go without them entirely.
The state also accuses Lodha of dispensing incorrect dosages, packages with missing pills, and medications in containers with broken safety seals. Officials say her conduct is alleged to have contributed to the deterioration of patients' medical conditions, jeopardized their safety, and caused adverse health consequences.
Filth and Expired Stock Uncovered
State inspectors conducting the investigation that began in 2024 uncovered 120 containers of expired medications stored within Woodbury Family Pharmacy's active drug stock, alongside severe filth and physical disorder, according to Patch. The presence of expired drugs mixed into active inventory formed a key basis for the State Board of Pharmacy's determination that Woodbury's drug stock was unsafe and unfit for distribution.
During board proceedings in June 2026, Lodha denied the allegations, Patch reported. The board ratified her license suspension on June 24, 2026, Patch reported. The board had granted the temporary suspension of both Lodha's license and Woodbury's operating permit on June 5, 2026, after the state argued her practice posed a clear and imminent danger to public health, safety and welfare.
From Suspension to Forced Sale
Daily Voice reported that Lodha continued to fill and dispense prescriptions while suspended using medications drawn from Woodbury's drug stock — stock the board had already deemed unfit for distribution.
Davenport said officials will act when pharmacists harm patients.
Division of Consumer Affairs Acting Director Jeremy E. Hollander said the conduct described in the case put public health and safety at risk. “New Jersey consumers are entitled to safe access to their prescription medications,” Hollander said.
Strict Limits Under the Consent Order
Under the September 1 interim consent order, reported by Daily Voice, Lodha is barred from entering Woodbury Family Pharmacy except to facilitate the sale or to participate in insurance audits, and even then she must be accompanied by a state-approved monitor. The suspension remains in place pending a plenary hearing.
The filings identify Division of Consumer Affairs Acting Director Jeremy E. Hollander in connection with the administrative action following an administrative complaint filed in May 2026, according to filings from the New Jersey Office of the Attorney General. Daily Voice also reported the terms of the divestment agreement.
A Long-Running South Jersey Practice
Woodbury Family Pharmacy, located at 160 North Broad Street in the Gloucester County seat, operated as a pharmacy, according to directory records from MaxorPlus. The available records cited here do not establish a corporate name or prior federal litigation for the business.
The available records cited here do not establish when Lodha began practicing pharmacy in South Jersey or any ties to Marlton Pharmacy or presentations on functional medicine and holistic health therapies. The forced sale, if completed within the 90-day window set by the consent order, would end her direct financial stake in the Woodbury operation while the underlying allegations against her remain unresolved.
